Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1991 Feb;91:9–16. doi: 10.1289/ehp.91919

Physiology of bone: mineral compartment proteins as candidates for environmental perturbation by lead.

J J Sauk 1, M J Somerman 1
PMCID: PMC1519352  PMID: 2040255

Abstract

Termine et al. first demonstrated that sequential dissociative extraction and fractionation procedures with protease inhibitors could provide a convenient approach for the study of mineral compartment constituents. The primary extraction regimen used 4 M guanidine HCl to remove most of the protein from the nonmineralized phase of bone. Subsequently, EDTA-guanidine was used to remove the mineral-phase components. These methods discriminate on the basis of physical-chemical association with a mineral phase rather than on the specific gene products of a particular cell. In the present discussion emphasis is directed at a group of divalent cation binding proteins isolated from the mineral compartment of bone. The localization, synthesis, and chemical characteristics of osteonectin, bone sialoproteins I and II, and bone acidic glycoprotein-75 are discussed and offered as possible sites for perturbation by the environment with lead exposure.

Full text

PDF
9

Images in this article

10FIGURE 1.
on p.10
13FIGURE 2.
on p.13
13FIGURE 2.
on p.13
13FIGURE 2.
on p.13
13FIGURE 3.
on p.13
13FIGURE 3.
on p.13
13FIGURE 3.
on p.13
13FIGURE 3.
on p.13

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albini A., Allavena G., Melchiori A., Giancotti F., Richter H., Comoglio P. M., Parodi S., Martin G. R., Tarone G. Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell-attachment site in fibronectin and a fibronectin cell surface receptor. J Cell Biol. 1987 Oct;105(4):1867–1872. doi: 10.1083/jcb.105.4.1867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andersen R. D., Taplitz S. J., Wong S., Bristol G., Larkin B., Herschman H. R. Metal-dependent binding of a factor in vivo to the metal-responsive elements of the metallothionein 1 gene promoter. Mol Cell Biol. 1987 Oct;7(10):3574–3581. doi: 10.1128/mcb.7.10.3574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bar-Shavit Z., Kahn A. J., Teitelbaum S. L. Defective binding of macrophages to bone in rodent osteomalacia and vitamin D deficiency. In vitro evidence for a cellular defect and altered saccharides in the bone matrix. J Clin Invest. 1983 Aug;72(2):526–534. doi: 10.1172/JCI111000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Benoist C., O'Hare K., Breathnach R., Chambon P. The ovalbumin gene-sequence of putative control regions. Nucleic Acids Res. 1980 Jan 11;8(1):127–142. doi: 10.1093/nar/8.1.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bianco P., Hayashi Y., Silvestrini G., Termine J. D., Bonucci E. Osteonectin and Gla-protein in calf bone: ultrastructural immunohistochemical localization using the Protein A-gold method. Calcif Tissue Int. 1985 Dec;37(6):684–686. doi: 10.1007/BF02554931. [DOI] [PubMed] [Google Scholar]
  6. Bolander M. E., Young M. F., Fisher L. W., Yamada Y., Termine J. D. Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor (ovomucoid). Proc Natl Acad Sci U S A. 1988 May;85(9):2919–2923. doi: 10.1073/pnas.85.9.2919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Craig A. M., Nemir M., Mukherjee B. B., Chambers A. F., Denhardt D. T. Identification of the major phosphoprotein secreted by many rodent cell lines as 2ar/osteopontin: enhanced expression in H-ras-transformed 3T3 cells. Biochem Biophys Res Commun. 1988 Nov 30;157(1):166–173. doi: 10.1016/s0006-291x(88)80028-7. [DOI] [PubMed] [Google Scholar]
  8. Dziadek M., Paulsson M., Aumailley M., Timpl R. Purification and tissue distribution of a small protein (BM-40) extracted from a basement membrane tumor. Eur J Biochem. 1986 Dec 1;161(2):455–464. doi: 10.1111/j.1432-1033.1986.tb10466.x. [DOI] [PubMed] [Google Scholar]
  9. Findlay D. M., Fisher L. W., McQuillan C. I., Termine J. D., Young M. F. Isolation of the osteonectin gene: evidence that a variable region of the osteonectin molecule is encoded within one exon. Biochemistry. 1988 Mar 8;27(5):1483–1489. doi: 10.1021/bi00405a013. [DOI] [PubMed] [Google Scholar]
  10. Fisher L. W., Hawkins G. R., Tuross N., Termine J. D. Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. J Biol Chem. 1987 Jul 15;262(20):9702–9708. [PubMed] [Google Scholar]
  11. Frazier W. A. Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells. J Cell Biol. 1987 Aug;105(2):625–632. doi: 10.1083/jcb.105.2.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gidoni D., Dynan W. S., Tjian R. Multiple specific contacts between a mammalian transcription factor and its cognate promoters. 1984 Nov 29-Dec 5Nature. 312(5993):409–413. doi: 10.1038/312409a0. [DOI] [PubMed] [Google Scholar]
  13. Gorski J. P., Shimizu K. Isolation of new phosphorylated glycoprotein from mineralized phase of bone that exhibits limited homology to adhesive protein osteopontin. J Biol Chem. 1988 Nov 5;263(31):15938–15945. [PubMed] [Google Scholar]
  14. Gronowicz G., Egan J. J., Rodan G. A. The effect of 1,25-dihydroxyvitamin D3 on the cytoskeleton of rat calvaria and rat osteosarcoma (ROS 17/2.8) osteoblastic cells. J Bone Miner Res. 1986 Oct;1(5):441–455. doi: 10.1002/jbmr.5650010509. [DOI] [PubMed] [Google Scholar]
  15. HERRING G. M., KENT P. W. SOME STUDIES ON MUCOSUBSTANCES OF BOVINE CORTICAL BONE. Biochem J. 1963 Dec;89:405–414. doi: 10.1042/bj0890405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Holland P. W., Harper S. J., McVey J. H., Hogan B. L. In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization. J Cell Biol. 1987 Jul;105(1):473–482. doi: 10.1083/jcb.105.1.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hynes R. O. Integrins: a family of cell surface receptors. Cell. 1987 Feb 27;48(4):549–554. doi: 10.1016/0092-8674(87)90233-9. [DOI] [PubMed] [Google Scholar]
  18. Jundt G., Berghäuser K. H., Termine J. D., Schulz A. Osteonectin--a differentiation marker of bone cells. Cell Tissue Res. 1987 May;248(2):409–415. doi: 10.1007/BF00218209. [DOI] [PubMed] [Google Scholar]
  19. Kinne R. W., Fisher L. W. Keratan sulfate proteoglycan in rabbit compact bone is bone sialoprotein II. J Biol Chem. 1987 Jul 25;262(21):10206–10211. [PubMed] [Google Scholar]
  20. Landesman R., Reddi A. H. Chemotaxis of muscle-derived mesenchymal cells to bone-inductive proteins of rat. Calcif Tissue Int. 1986 Oct;39(4):259–262. doi: 10.1007/BF02555215. [DOI] [PubMed] [Google Scholar]
  21. Lefevre C., Imagawa M., Dana S., Grindlay J., Bodner M., Karin M. Tissue-specific expression of the human growth hormone gene is conferred in part by the binding of a specific trans-acting factor. EMBO J. 1987 Apr;6(4):971–981. doi: 10.1002/j.1460-2075.1987.tb04847.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lucas P. A., Syftestad G. T., Caplan A. I. Partial isolation and characterization of a chemotactic factor from adult bovine bone for mesenchymal cells. Bone. 1986;7(5):365–371. doi: 10.1016/8756-3282(86)90257-7. [DOI] [PubMed] [Google Scholar]
  23. Mark M. P., Butler W. T., Prince C. W., Finkelman R. D., Ruch J. V. Developmental expression of 44-kDa bone phosphoprotein (osteopontin) and bone gamma-carboxyglutamic acid (Gla)-containing protein (osteocalcin) in calcifying tissues of rat. Differentiation. 1988;37(2):123–136. doi: 10.1111/j.1432-0436.1988.tb00804.x. [DOI] [PubMed] [Google Scholar]
  24. Mark M. P., Prince C. W., Gay S., Austin R. L., Bhown M., Finkelman R. D., Butler W. T. A comparative immunocytochemical study on the subcellular distributions of 44 kDa bone phosphoprotein and bone gamma-carboxyglutamic acid (Gla)-containing protein in osteoblasts. J Bone Miner Res. 1987 Aug;2(4):337–346. doi: 10.1002/jbmr.5650020411. [DOI] [PubMed] [Google Scholar]
  25. Mark M. P., Prince C. W., Gay S., Austin R. L., Butler W. T. 44-kDal bone phosphoprotein (osteopontin) antigenicity at ectopic sites in newborn rats: kidney and nervous tissues. Cell Tissue Res. 1988 Jan;251(1):23–30. doi: 10.1007/BF00215443. [DOI] [PubMed] [Google Scholar]
  26. Mark M. P., Prince C. W., Oosawa T., Gay S., Bronckers A. L., Butler W. T. Immunohistochemical demonstration of a 44-KD phosphoprotein in developing rat bones. J Histochem Cytochem. 1987 Jul;35(7):707–715. doi: 10.1177/35.7.3295029. [DOI] [PubMed] [Google Scholar]
  27. Marks S. C., Jr, Popoff S. N. Bone cell biology: the regulation of development, structure, and function in the skeleton. Am J Anat. 1988 Sep;183(1):1–44. doi: 10.1002/aja.1001830102. [DOI] [PubMed] [Google Scholar]
  28. Mason I. J., Murphy D., Münke M., Francke U., Elliott R. W., Hogan B. L. Developmental and transformation-sensitive expression of the Sparc gene on mouse chromosome 11. EMBO J. 1986 Aug;5(8):1831–1837. doi: 10.1002/j.1460-2075.1986.tb04434.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mason I. J., Taylor A., Williams J. G., Sage H., Hogan B. L. Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial cell 'culture shock' glycoprotein of Mr 43,000. EMBO J. 1986 Jul;5(7):1465–1472. doi: 10.1002/j.1460-2075.1986.tb04383.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. McVey J. H., Nomura S., Kelly P., Mason I. J., Hogan B. L. Characterization of the mouse SPARC/osteonectin gene. Intron/exon organization and an unusual promoter region. J Biol Chem. 1988 Aug 15;263(23):11111–11116. [PubMed] [Google Scholar]
  31. Melcher A. H. On the repair potential of periodontal tissues. J Periodontol. 1976 May;47(5):256–260. doi: 10.1902/jop.1976.47.5.256. [DOI] [PubMed] [Google Scholar]
  32. Noda M., Rodan G. A. Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone. J Cell Biol. 1989 Feb;108(2):713–718. doi: 10.1083/jcb.108.2.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Noda M., Rodan G. A. Type beta transforming growth factor (TGF beta) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cells. J Cell Physiol. 1987 Dec;133(3):426–437. doi: 10.1002/jcp.1041330303. [DOI] [PubMed] [Google Scholar]
  34. Nomura S., Wills A. J., Edwards D. R., Heath J. K., Hogan B. L. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol. 1988 Feb;106(2):441–450. doi: 10.1083/jcb.106.2.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Oldberg A., Franzén A., Heinegård D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci U S A. 1986 Dec;83(23):8819–8823. doi: 10.1073/pnas.83.23.8819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Oldberg A., Franzén A., Heinegård D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci U S A. 1986 Dec;83(23):8819–8823. doi: 10.1073/pnas.83.23.8819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Oldberg A., Franzén A., Heinegård D., Pierschbacher M., Ruoslahti E. Identification of a bone sialoprotein receptor in osteosarcoma cells. J Biol Chem. 1988 Dec 25;263(36):19433–19436. [PubMed] [Google Scholar]
  38. Oldberg A., Franzén A., Heinegård D. The primary structure of a cell-binding bone sialoprotein. J Biol Chem. 1988 Dec 25;263(36):19430–19432. [PubMed] [Google Scholar]
  39. Polla B. S., Healy A. M., Amento E. P., Krane S. M. 1,25-Dihydroxyvitamin D3 maintains adherence of human monocytes and protects them from thermal injury. J Clin Invest. 1986 Apr;77(4):1332–1339. doi: 10.1172/JCI112438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Prince C. W., Butler W. T. 1,25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells. Coll Relat Res. 1987 Sep;7(4):305–313. doi: 10.1016/s0174-173x(87)80036-5. [DOI] [PubMed] [Google Scholar]
  41. Pytela R., Pierschbacher M. D., Argraves S., Suzuki S., Ruoslahti E. Arginine-glycine-aspartic acid adhesion receptors. Methods Enzymol. 1987;144:475–489. doi: 10.1016/0076-6879(87)44196-7. [DOI] [PubMed] [Google Scholar]
  42. Reddi A. H., Huggins C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Natl Acad Sci U S A. 1972 Jun;69(6):1601–1605. doi: 10.1073/pnas.69.6.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Romberg R. W., Werness P. G., Riggs B. L., Mann K. G. Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry. 1986 Mar 11;25(5):1176–1180. doi: 10.1021/bi00353a035. [DOI] [PubMed] [Google Scholar]
  44. Rosenfeld P. J., Kelly T. J. Purification of nuclear factor I by DNA recognition site affinity chromatography. J Biol Chem. 1986 Jan 25;261(3):1398–1408. [PubMed] [Google Scholar]
  45. Ross R. The fibroblast and wound repair. Biol Rev Camb Philos Soc. 1968 Feb;43(1):51–96. doi: 10.1111/j.1469-185x.1968.tb01109.x. [DOI] [PubMed] [Google Scholar]
  46. Ruoslahti E., Pierschbacher M. D. New perspectives in cell adhesion: RGD and integrins. Science. 1987 Oct 23;238(4826):491–497. doi: 10.1126/science.2821619. [DOI] [PubMed] [Google Scholar]
  47. Sage H., Tupper J., Bramson R. Endothelial cell injury in vitro is associated with increased secretion of an Mr 43,000 glycoprotein ligand. J Cell Physiol. 1986 Jun;127(3):373–387. doi: 10.1002/jcp.1041270305. [DOI] [PubMed] [Google Scholar]
  48. Sampath T. K., Nathanson M. A., Reddi A. H. In vitro transformation of mesenchymal cells derived from embryonic muscle into cartilage in response to extracellular matrix components of bone. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3419–3423. doi: 10.1073/pnas.81.11.3419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Senger D. R., Perruzzi C. A., Gracey C. F., Papadopoulos A., Tenen D. G. Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res. 1988 Oct 15;48(20):5770–5774. [PubMed] [Google Scholar]
  50. Senger D. R., Perruzzi C. A. Secreted phosphoprotein markers for neoplastic transformation of human epithelial and fibroblastic cells. Cancer Res. 1985 Nov;45(11 Pt 2):5818–5823. [PubMed] [Google Scholar]
  51. Short J. M., Wynshaw-Boris A., Short H. P., Hanson R. W. Characterization of the phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region. II. Identification of cAMP and glucocorticoid regulatory domains. J Biol Chem. 1986 Jul 25;261(21):9721–9726. [PubMed] [Google Scholar]
  52. Smith J. H., Denhardt D. T. Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities. J Cell Biochem. 1987 May;34(1):13–22. doi: 10.1002/jcb.240340103. [DOI] [PubMed] [Google Scholar]
  53. Somerman M. J., Fisher L. W., Foster R. A., Sauk J. J. Human bone sialoprotein I and II enhance fibroblast attachment in vitro. Calcif Tissue Int. 1988 Jul;43(1):50–53. doi: 10.1007/BF02555169. [DOI] [PubMed] [Google Scholar]
  54. Somerman M. J., Foster R. A., Imm G. M., Sauk J. J., Archer S. Y. Periodontal ligament cells and gingival fibroblasts respond differently to attachment factors in vitro. J Periodontol. 1989 Feb;60(2):73–77. doi: 10.1902/jop.1989.60.2.73. [DOI] [PubMed] [Google Scholar]
  55. Somerman M. J., Hotchkiss R. N., Bowers M. R., Termine J. Comparison of fetal and adult human bone: identification of a chemotactic factor in fetal bone. Metab Bone Dis Relat Res. 1983;5(2):75–79. doi: 10.1016/0221-8747(83)90005-x. [DOI] [PubMed] [Google Scholar]
  56. Somerman M. J., Perez-Mera M., Merkhofer R. M., Foster R. A. In vitro evaluation of extracts of mineralized tissues for their application in attachment of fibrous tissue. J Periodontol. 1987 May;58(5):349–351. doi: 10.1902/jop.1987.58.5.349. [DOI] [PubMed] [Google Scholar]
  57. Somerman M. J., Prince C. W., Butler W. T., Foster R. A., Moehring J. M., Sauk J. J. Cell attachment activity of the 44 kilodalton bone phosphoprotein is not restricted to bone cells. Matrix. 1989 Jan;9(1):49–54. doi: 10.1016/s0934-8832(89)80018-6. [DOI] [PubMed] [Google Scholar]
  58. Somerman M. J., Prince C. W., Sauk J. J., Foster R. A., Butler W. T. Mechanism of fibroblast attachment to bone extracellular matrix: role of a 44 kilodalton bone phosphoprotein. J Bone Miner Res. 1987 Jun;2(3):259–265. doi: 10.1002/jbmr.5650020313. [DOI] [PubMed] [Google Scholar]
  59. Somerman M., Hewitt A. T., Varner H. H., Schiffmann E., Termine J., Reddi A. H. Identification of a bone matrix-derived chemotactic factor. Calcif Tissue Int. 1983 Jul;35(4-5):481–485. doi: 10.1007/BF02405081. [DOI] [PubMed] [Google Scholar]
  60. Somerman M., Schiffmann E., Reddi A. H., Termine J. Regulation of the attachment and migration of bone cells in vitro. J Periodontal Res. 1982 Sep;17(5):527–529. doi: 10.1111/j.1600-0765.1982.tb02047.x. [DOI] [PubMed] [Google Scholar]
  61. Stenner D. D., Tracy R. P., Riggs B. L., Mann K. G. Human platelets contain and secrete osteonectin, a major protein of mineralized bone. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6892–6896. doi: 10.1073/pnas.83.18.6892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Suzuki S., Argraves W. S., Arai H., Languino L. R., Pierschbacher M. D., Ruoslahti E. Amino acid sequence of the vitronectin receptor alpha subunit and comparative expression of adhesion receptor mRNAs. J Biol Chem. 1987 Oct 15;262(29):14080–14085. [PubMed] [Google Scholar]
  63. Termine J. D., Belcourt A. B., Conn K. M., Kleinman H. K. Mineral and collagen-binding proteins of fetal calf bone. J Biol Chem. 1981 Oct 25;256(20):10403–10408. [PubMed] [Google Scholar]
  64. Termine J. D., Kleinman H. K., Whitson S. W., Conn K. M., McGarvey M. L., Martin G. R. Osteonectin, a bone-specific protein linking mineral to collagen. Cell. 1981 Oct;26(1 Pt 1):99–105. doi: 10.1016/0092-8674(81)90037-4. [DOI] [PubMed] [Google Scholar]
  65. Urist M. R. Bone histogenesis and morphogenesis in implants of demineralized enamel and dentin. J Oral Surg. 1971 Feb;29(2):88–102. [PubMed] [Google Scholar]
  66. Wewer U. M., Albrechtsen R., Fisher L. W., Young M. F., Termine J. D. Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues characterized by de novo formation of basement membrane. Am J Pathol. 1988 Aug;132(2):345–355. [PMC free article] [PubMed] [Google Scholar]
  67. Wiederrecht G., Shuey D. J., Kibbe W. A., Parker C. S. The Saccharomyces and Drosophila heat shock transcription factors are identical in size and DNA binding properties. Cell. 1987 Feb 13;48(3):507–515. doi: 10.1016/0092-8674(87)90201-7. [DOI] [PubMed] [Google Scholar]
  68. Yoon K., Buenaga R., Rodan G. A. Tissue specificity and developmental expression of rat osteopontin. Biochem Biophys Res Commun. 1987 Nov 13;148(3):1129–1136. doi: 10.1016/s0006-291x(87)80250-4. [DOI] [PubMed] [Google Scholar]
  69. Young M. F., Bolander M. E., Day A. A., Ramis C. I., Robey P. G., Yamada Y., Termine J. D. Osteonectin mRNA: distribution in normal and transformed cells. Nucleic Acids Res. 1986 Jun 11;14(11):4483–4497. doi: 10.1093/nar/14.11.4483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Young M. F., Findlay D. M., Dominguez P., Burbelo P. D., McQuillan C., Kopp J. B., Robey P. G., Termine J. D. Osteonectin promoter. DNA sequence analysis and S1 endonuclease site potentially associated with transcriptional control in bone cells. J Biol Chem. 1989 Jan 5;264(1):450–456. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES